Literature DB >> 32201671

TXNDC5 protects synovial fibroblasts of rheumatoid arthritis from the detrimental effects of endoplasmic reticulum stress.

Qiqi Lu1, Jinguang Wang2, Xiumei Zhang3, Ruisong Tian4, Li Qiao5, Luna Ge4, Jihong Pan4, Lin Wang4.   

Abstract

TXNDC5 is an endoplasmic reticulum (ER)-resident chaperone that protects the endothelium from secondary effects of ER stress. Previous studies by the current authors identified TXNDC5 as a key pathological factor in promoting the inflammatory phenotype of fibroblast-like synoviocytes (FLSs) from rheumatoid arthritis (RA). However, its activity in RA FLSs under ER stress remains unclear. The current study found that TXNDC5 is responsive to ER stress in RA FLSs since its expression was induced by ER stress at both the endogenous and secretory level. A functional study indicated that silencing TXNDC5 reduced the viability of RA FLSs more markedly in the presence of ER stressors. In contrast, rhTXNDC5 attenuated a decrease in cell viability as a result of ER stress. Moreover, silencing TXNDC5 attenuated the induction of IL-6 and IL-8 from RA FLSs in response to ER stress. In addition, rhTXNDC5 induced a greater increase in VEGF production during ER stress. These findings confirm the pro-survival and pro-inflammation roles of TXNDC5 under ER stress in RA FLSs. TXNDC5 appears to act as a mediator linking ER stress and inflammation of RA. 2020, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  TXNDC5; endoplasmic reticulum stress; rheumatoid arthritis

Year:  2020        PMID: 32201671      PMCID: PMC7062600          DOI: 10.5582/irdr.2019.01139

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  3 in total

Review 1.  The role and mechanism of TXNDC5 in diseases.

Authors:  Xueling Wang; Haoran Li; Xiaotian Chang
Journal:  Eur J Med Res       Date:  2022-08-08       Impact factor: 4.981

2.  Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma.

Authors:  Deze Zhao; Xianyu Liu; Yunhan Shan; JiaJia Li; Weifang Cui; Jun Wang; Junjie Jiang; Qun Xie; Chunfang Zhang; Chaojun Duan
Journal:  Comput Struct Biotechnol J       Date:  2022-09-05       Impact factor: 6.155

3.  Thioredoxin Domain Containing 5 Suppression Elicits Serum Amyloid A-Containing High-Density Lipoproteins.

Authors:  Javier Sánchez-Marco; Roberto Martínez-Beamonte; Alicia De Diego; Tania Herrero-Continente; Cristina Barranquero; Carmen Arnal; Joaquín Surra; María A Navarro; Jesús Osada
Journal:  Biomedicines       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.